Back to top
more

Medpace (MEDP)

(Delayed Data from NSDQ)

$397.56 USD

397.56
423,449

-9.59 (-2.36%)

Updated Apr 24, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (80 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for MEDP

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Medpace Holdings, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 245 28 461 278 132
Receivables 298 253 186 161 156
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 50 52 43 35 29
Total Current Assets 594 334 691 474 317
Net Property & Equipment 121 110 93 85 47
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 74 48 25 1 0
Intangibles 698 700 704 709 717
Deposits & Other Assets 25 21 17 9 9
Total Assets 1,657 1,353 1,660 1,391 1,143
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 32 33 26 27 22
Current Portion Long-Term Debt 0 50 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 293 210 159 134 109
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 600 510 372 279 211
Total Current Liabilities 925 803 557 440 343
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2 1 1 14 13
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 28 23 18 16 16
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,098 966 707 585 417
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 803 771 728 696 667
Retained Earnings -222 -360 235 115 68
Other Equity -10 -12 -5 0 -3
Treasury Stock 12 13 5 6 6
Total Shareholder's Equity 559 386 953 806 726
Total Liabilities & Shareholder's Equity 1,657 1,353 1,660 1,391 1,143
Total Common Equity 559 386 953 806 726
Shares Outstanding 30.60 31.10 35.90 35.70 36.00
Book Value Per Share 18.27 12.42 26.54 22.57 20.17

Fiscal Year End for Medpace Holdings, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 245 95 39 47
Receivables NA 298 293 275 258
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 50 61 65 63
Total Current Assets NA 594 449 379 368
Net Property & Equipment NA 121 115 115 114
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 74 59 52 49
Intangibles NA 698 699 699 700
Deposits & Other Assets NA 25 21 22 22
Total Assets NA 1,657 1,487 1,407 1,396
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 32 29 34 37
Current Portion Long-Term Debt NA 0 0 55 115
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 293 265 232 201
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 600 555 532 529
Total Current Liabilities NA 925 849 852 882
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 2 1 1 1
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 23 23 23
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,098 1,016 1,016 1,048
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 803 796 785 779
Retained Earnings NA -222 -300 -371 -408
Other Equity NA -10 -13 -11 -11
Treasury Stock NA 12 12 12 12
Total Shareholder's Equity NA 559 471 391 347
Total Liabilities & Shareholder's Equity NA 1,657 1,487 1,407 1,396
Total Common Equity 0 559 471 391 347
Shares Outstanding 30.90 30.60 30.60 30.50 30.50
Book Value Per Share 0.00 18.27 15.39 12.82 11.39